Buy, hold, sell: Catapult, Guzman Y Gomez, and Wesfarmers shares

The team at Morgans has been busy looking at a number of popular ASX shares this week.

Let’s see if the broker is bullish or bearish on these names. Here’s what it is saying:

Catapult Sports Ltd (ASX: CAT)

Morgans was pleased with this sports technology company’s performance in FY 2026, highlighting that its revenue and annualised contract value (ACV) were strong. But the biggest positive was arguably that operating leverage is starting to show.

In response, Morgans has retained its buy rating with a $5.40 price target. It said:

CAT’s FY26 result confirmed strong organic momentum, with revenue US$141m (+19% c/c) and closing ACV US$134m (+28% c/c) at the top of guidance, while Management EBITDA of US$25m (17.6% margin, +67% pcp) beat MorgansF. Operating leverage is now evident, with a 41% incremental margin (48% ex-acquisitions) in the period. ACV per pro team crossed US$30k for the first time whilst SaaS metrics improved. We trim FY27-FY29F Management EBITDA by 6-8% factoring in the result. Our price target is lowered to A$5.40 (from A$5.55) on these changes, offset to a degree by a valuation roll forward. BUY maintained.

Guzman Y Gomez Ltd (ASX: GYG)

The broker was pleased to see this quick service restaurant operator decide to close its US operations with immediate effect.

While this removes a potential growth engine, it also removes a loss-making part of the business that was weighing on its financial performance and simplifies its story.

Morgans has put a buy rating and $29.40 price target on Guzman Y Gomez shares. It said:

GYG announced the immediate exit of its US operations, a business that we forecast generated a significant FY26 underlying EBITDA loss and required materially more capital than could be justified by prospective returns. We view this as a positive catalyst, notwithstanding that the market has previously ascribed meaningful optionality value to the US as a long-term growth engine.

The exit removes a loss sooner than consensus anticipated and simplifies the story while the Australian operations are performing well and in line with expectations. Stripping out the US losses results in material upgrades to our EBITDA and NPAT forecasts. We maintain our BUY rating and upgrade our price target to A$29.40.

Wesfarmers Ltd (ASX: WES)

Morgans points out that the Bunnings and Kmart owner’s shares have pulled back meaningfully from their highs.

It believes this leaves Wesfarmers shares trading at more reasonable valuation. As a result, the broker has upgraded its shares to an accumulate rating with an $81.10 price target. It said:

WES’s share price has fallen 9% over the past 12 months and 7% over the past 6 months. The stock is now trading on a more reasonable 26.5x FY27F PE compared to a peak one-year forward multiple of ~37x in August 2025. We adjust FY26/27/28F group EBIT by +0%/+2%/+2%, primarily reflecting higher lithium earnings driven by updated price assumptions. Our target price increases slightly to $81.10 (from $80.50) and with a forecast 12-month TSR of 12%, we upgrade our rating to ACCUMULATE (from TRIM).

In our view, WES remains a high-quality business with a healthy balance sheet and a proven management team. Amid ongoing geopolitical uncertainty and cost-of-living pressures, its retail divisions (Bunnings, Kmart Group, Officeworks, Priceline) are well-placed to grow due to their strong value propositions. A sustained improvement in lithium prices should also support earnings over the medium term.

The post Buy, hold, sell: Catapult Sports, Guzman Y Gomez, and Wesfarmers shares appeared first on The Motley Fool Australia.

More reading

• With first-half profits jumping to $1.6 billion, are Wesfarmers shares a buy today?
• Why Fisher & Paykel Healthcare, GR Engineering, Kogan, and Wesfarmers shares are pushing higher
• Buy, hold, sell: Catapult Sports, Tower, Guzman y Gomez shares
• 5 things to watch on the ASX 200 on Tuesday
• Buying Wesfarmers shares today? Here’s the dividend yield you’ll get

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Catapult Sports and Wesfarmers. The Motley Fool Australia has positions in and has recommended Catapult Sports. The Motley Fool Australia has recommended Wesfarmers. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

A US$7 billion takeover rumoured to be on foot in the US could give investors a better sense of the upside in Telix Pharmaceuticals Ltd (ASX: TLX) shares, according to the team at Morgan Stanley.

Takeover talks behind closed doors

Bloomberg News has reported that private equity-backed Curium Pharma has made an approach to Lantheus Holdings, which operates in the same drug compound field as Telix – radiopharmaceuticals for use in the treatment of prostate cancer.

Neither company is commenting on the supposed deal; however, Morgan Stanley said the rumoured deal numbers could be used to extrapolate a value for Telix.

Lantheus and Telix were both “key players” in the field of prostate cancer detection, Morgan Stanley said, with Lantheus through its Pylarify compound and Telix through Illuccix and Gozellix.

The Morgan Stanley team said the deal price implies a higher multiple than Telix is trading at currently, and if the multiple were applied to Telix, a share price of $18.40 to $18.95 would be on the cards.

Morgan Stanley has also factored in the revenue and R&D guidance for this year from Telix, “and risk-weighted contributions from late-stage candidates”, and has come up with a 12-month price target of $22.40 for Telix shares.

This compares with the current share price of $12.83.

Business travelling well

Telix Chief Executive Officer Christian Behrenbuch told the company’s annual general meeting last week that the company’s core commercial business was performing “extremely well”, with the company continuing to take market share in the US.

He added:

In Q1 2026, our Precision Medicine revenue was up 11% quarter-on-quarter to US$186 million with 5% volume growth. We affirm our full-year 2026 Group revenue guidance of US$950 million to US$970 million based on strong uptake of Gozellix and continued growth from Illuccix. This guidance also includes revenue from RLS Radiopharmacies. We also affirm our previously stated research and development (R&D) expenditure guidance of US$200 million to US$240 million, subject to achieving ongoing global commercial milestones.

Mr Behrenbuch said the US remained the company’s primary revenue driver, but added that it was also expanding internationally, with Illuccix now available in 22 countries.

He added:

In January, we announced acceptance of the New Drug Application (NDA) for Illuccix in China9, while in Japan we continue to progress a Phase 3 bridging study. We are also preparing to advance our NDA submission under Japan’s conditional approval framework, with the objective of enabling earlier commercial access.  

Mr Behrenbuch said Telix was continuing to advance its therapeutic pipeline, “with multiple late-stage studies gaining momentum”.

Telix is valued at $4.56 billion.

The post What does a takeover in the US tell us about the value of Telix shares? appeared first on The Motley Fool Australia.

More reading

• 4 ASX 200 shares tipped to jump another 70-80%
• These are the 10 most shorted ASX shares
• These ASX 200 shares have been smashed. I think patient investors should pay attention
• Why I think DroneShield and these ASX growth shares could beat the market over 10 years
• These are the 10 most shorted ASX shares

Motley Fool contributor Cameron England has positions in Telix Pharmaceuticals. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Lantheus and Telix Pharmaceuticals. The Motley Fool Australia has recommended Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

S&P/ASX 200 Index (ASX: XJO) shares are down 0.4% to 8,655.2 points on Tuesday.

Among the 11 market sectors, consumer discretionary shares are in the lead, up 0.3%, while utilities are the laggard, down 1.9%.

Let’s find out how the experts rate three stocks across three different sectors today.

Argo Investments Ltd (ASX: ARG)

The Argo Investments share price is $8.80, down 0.1% today and 3% over the past six months.

Jed Richards from Shaw and Partners has a buy rating on this listed investment company (LIC).

He explained why on The Bull this week:

This listed investment company is trading at a material discount to its underlying asset value, offering an attractive entry point.

It provides broad diversity across leading Australian companies and pays a reliable fully franked dividend yield, which was recently above 4.4 per cent.

Recent results highlight steady income growth and a strong balance sheet. Its conservative style suits investors seeking income and stability.

Buying at a discount enhances long term return potential, while maintaining exposure to high quality Australian equities.

Amcor CDI (ASX: AMC)

The Amcor share price is $54.50, down 0.8% today and 17% over the past six months.

Richards gives Amcor shares a hold rating.

He said: 

This packaging giant continues to face pressure from elevated input costs, particularly linked to higher oil and plastic prices, which have impacted margins. Despite this, the company maintains strong global operations and continues to generate stable cash flow.

A weaker share price provides an attractive dividend yield for income investors.

Recent updates indicate increased costs have been passed through to customers.

Holding is appropriate given its defensive packaging exposure, but upside will likely depend on managing input costs.

Bapcor Ltd (ASX: BAP)

The Bapcor share price is 39 cents, up 1.3% today but down a demoralising 77% over six months.

Mark Elzayed from Investor Pulse has a sell rating on this consumer discretionary share.

Elzayed said: 

Bapcor is an aftermarket automotive parts provider in Australia and New Zealand. It operates the Autobarn, Burson and Autopro brands.

It reported improving sales from turnaround activities between February and April 2026. However, trading conditions had materially deteriorated since late March 2026 in response to the Middle East conflict and an increase in interest rates.

It has reduced fiscal year 2026 earnings guidance on what it provided on February 26, 2026. The company also flagged higher operating costs.

The share price remains under pressure. The stock has fallen from $5.22 on July 14, 2025 to trade at 38 cents on May 21, 2026.

Better options exist elsewhere, in our view.

The post Buy, hold, sell: Argo Investments, Amcor, Bapcor shares appeared first on The Motley Fool Australia.

More reading

• Analysts name 3 ASX shares to sell now
• Experts recommend CBA and these ASX shares as buys
• I’d listen to Warren Buffett and load up on cheap ASX shares
• How much is needed in superannuation to target a $7,500 monthly passive income?
• Could this boring ASX 200 dividend share be a strong buy for its big yield?

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended Amcor Plc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

GR Engineering Services Ltd (ASX: GNG) shares are having a big session on Tuesday after the engineering contractor was named across several fresh project updates.

At the time of writing, the GR Engineering share price is up 5.76% to $5.51.

Earlier today, the stock climbed as high as $5.62, marking a new all-time high.

Some profit-taking has since come through, but it has still been a strong day for shareholders.

GR Engineering shares are now up around 24% in 2026 and 92% over the past year.

The latest move comes as investors react to more contract work across the mining and processing sector.

Here’s what was announced.

More work at Laverton

GR Engineering said it has locked in an engineering, procurement and construction contract with Brightstar Resources Ltd (ASX: BTR).

The contract relates to Brightstar’s Laverton Processing Plant in Western Australia.

The company was appointed as the preferred contractor for the project on 17 February, and early works and long-lead item procurement have already commenced.

The contract sum is $110 million.

Brightstar also released its own update today, confirming a final investment decision for its Goldfields Project.

The company said construction of the 1.5 million tonne per annum Laverton plant has now been approved.

It also said first gold remains on track for June 2027.

Sorby Hills adds another contract

The Laverton contract was not the only update involving GR Engineering today.

Boab Metals Ltd (ASX: BML) also confirmed that it has executed an EPC contract with GR Engineering for its Sorby Hills silver-lead project.

Sorby Hills is located in the Kimberley region of Western Australia.

The contract covers the disassembly, refurbishment, and relocation of the existing DeGrussa processing plant to Sorby Hills.

Once moved, the plant will be reconstructed and commissioned to suit Boab’s requirements.

Boab said the EPC contract has a value of $109 million.

Early engineering works and ordering of long-lead items have started, with construction teams expected to mobilise in the coming weeks.

The company said on-site development at Sorby Hills is ramping up, with commercial concentrate production still on track for the second half of 2027.

Why the new work stands out

The market appears to be rewarding the size and spread of the new work.

GR Engineering has now been linked to about $219 million of EPC contract work across the Laverton and Sorby Hills updates.

That is a decent amount of new work for a business that was worth about $887 million before today’s rise.

It also comes during a busy run for the contractor, with recent work tied to the Dayhurst Expansion Project, Tower Hill Project, and Beetalo Basin.

The latest contracts also show GR Engineering is still finding work as miners move projects closer to construction.

The post Record high: This ASX stock is surging on new project wins appeared first on The Motley Fool Australia.

More reading

• Looking to 4x your money? Shaw and Partners has tipped this miner for big things
• Why Fisher & Paykel Healthcare, GR Engineering, Kogan, and Wesfarmers shares are pushing higher
• Why Brightstar, Catapult Sports, IperionX, and Zip shares are charging higher
• Up 75% in a year, this ASX stock just landed a $229 million contract
• Up 33% since March, why is this ASX All Ords gold stock outperforming again today?

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Wesfarmers Ltd (ASX: WES) shares are marching higher today.

Shares in the S&P/ASX 200 Index (ASX: XJO) conglomerate – whose retail subsidiaries include Bunnings Warehouse, Kmart Australia, Officeworks, and Priceline – closed yesterday trading for $75.80. In afternoon trade on Tuesday, shares are changing hands for $77.36 apiece, up 2.1%.

For some context, the ASX 200 is down 0.4% at this same time.

With today’s intraday gains factored in, Wesfarmers shares are now up 8.4% since last Monday’s close.

Despite that recent outperformance, the ASX 200 stock remains down 6.5% over the last 12 months, trailing the 3.6% one-year gains delivered by the benchmark index.

Though we shouldn’t discount the two fully-franked dividends totalling $1.42 a share that Wesfarmers paid to eligible stockholders over the year. Wesfarmers trades on a 1.8% fully-franked trailing dividend yield.

Which brings us back to our headline question.

With both Wesfarmers dividends and profits on the rise over the half-year (H1 FY 2026), should you buy the ASX 200 stock today?

Wesfarmers shares: Buy, hold or sell?

Investor Pulse’s Mark Elzayed recently analysed the outlook for Wesfarmers stock (courtesy of The Bull).

“Wesfarmers is a diversified industrial conglomerate,” he said. “It owns market leading businesses, including Bunnings, Kmart and Officeworks, generating resilient earnings, even in softer economic conditions.”

Explaining his current hold recommendation for Wesfarmers shares, Elzayed said:

We believe it makes sense to hold Wesfarmers given it generated net profit after tax of $1.603 billion in the first half of 2026, up 9.3% on the prior corresponding period. Revenue of $24.2 billion was up 3.1%.

Noting the increased passive income payout on the back of those half-year results, Elzayed concluded:

Bunnings and Kmart continued delivering strong sales growth. The group also lifted its fully franked interim dividend by 7.4% to $1.02 a share, highlighting confidence in cash generation and balance sheet strength.

What else did the ASX 200 stock report?

Wesfarmers shares closed down 5.6% on 19 February following the release of the company’s first-half results, despite the strong profit, revenue, and dividend growth Elzayed noted above.

Commenting on what helped drive that growth, Wesfarmers managing director Rob Scott said, “Wesfarmers’ increase in profit was supported by strong earnings contributions from our largest divisions – Bunnings, Kmart Group and WesCEF.”

Indeed, while the company is better known for its retail assets, Wesfarmers is also engaged in lithium mining.

At the half-year results, Scott noted:

WesCEF’s earnings benefited from a positive contribution from its lithium business, supported by the strong performance of the mine and concentrator and a significantly improved pricing environment later in the half.

The post With first half profits jumping to $1.6 billion, are Wesfarmers shares a buy today? appeared first on The Motley Fool Australia.

More reading

• Why Fisher & Paykel Healthcare, GR Engineering, Kogan, and Wesfarmers shares are pushing higher
• 5 things to watch on the ASX 200 on Tuesday
• Buying Wesfarmers shares today? Here’s the dividend yield you’ll get
• How to start investing in ASX shares in 2026
• Buy, hold, sell: L1 Long Short Fund, Metcash, and Wesfarmers shares

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Wesfarmers. The Motley Fool Australia has recommended Wesfarmers. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a decline. At the time of writing, the benchmark index is down 0.4% to 8,658.3 points.

Four ASX shares that are not letting that hold them back today are listed below. Here’s why they are rising:

Fisher & Paykel Healthcare Corporation Ltd (ASX: FPH)

The Fisher & Paykel Healthcare share price is up 7% to $29.66. Investors have been buying this medical device company’s shares following the release of a strong FY 2026 result. Fisher & Paykel Healthcare reported a 14% increase in total operating revenue to NZ$2.31 billion and a 24% increase in net profit after tax to NZ$469.5 million for FY 2026. The company’s CEO, Lewis Gradon, said: “Our Hospital business performed strongly across the portfolio of therapies globally. We were especially encouraged by consumables growth, given it occurred during a period in which hospital admissions for seasonal respiratory illnesses in the United States and other major markets appeared to be subdued compared to the previous year. This suggests that changing clinical practice continues to be a strong growth driver.”

GR Engineering Services Ltd (ASX: GNG)

The GR Engineering Services share price is up 5.5% to $5.50. This morning, this engineering services company won an engineering, procurement and construction (EPC) contract from Boab Metals Ltd (ASX: BML). This is in relation to the Sorby Hills Silver-Lead Project, which is located 50 km from Kununurra in Western Australia. The company estimates that the contract is worth $109 million.

Kogan.com Ltd (ASX: KGN)

The Kogan share price is up 16% to $3.99. The catalyst for this has been the release of a trading update from the ecommerce company this morning. For the 10 months ended 30 April, Kogan reported total gross sales growth of 13.2% to $875.6 million and a 25.4% increase in group adjusted EBIT to $26.9 million. This was driven by a strong performance from the core Kogan business and a much-improved performance from the Mighty Ape business. It said: “The Company delivered a Group Adjusted EBITDA margin of 8.6%, towards the upper end of previously provided FY26 guidance, which includes the impact of the turnaround of Mighty Ape. This performance was driven by strong profitability within Kogan.com, which achieved Adjusted EBITDA margin of 11.5%, together with materially improved performance at Mighty Ape in the most recent four months to 30 April 2026.”

Wesfarmers Ltd (ASX: WES)

The Wesfarmers share price is up almost 2% to $77.14. This may have been driven by a broker note out of Morgans. It has upgraded the Bunnings owner’s shares to an accumulate rating (from trim) with a slightly improved price target of $81.10 (from $80.50). It said: “WES’s share price has fallen 9% over the past 12 months and 7% over the past 6 months. The stock is now trading on a more reasonable 26.5x FY27F PE compared to a peak one-year forward multiple of ~37x in August 2025.”

The post Why Fisher & Paykel Healthcare, GR Engineering, Kogan, and Wesfarmers shares are pushing higher appeared first on The Motley Fool Australia.

More reading

• With first half profits jumping to $1.6 billion, are Wesfarmers shares a buy today?
• Guess which ASX All Ords share is rocketing 20% on big news
• Guess which ASX 200 stock is jumping 9% on FY26 results
• 5 things to watch on the ASX 200 on Tuesday
• Buying Wesfarmers shares today? Here’s the dividend yield you’ll get

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Kogan.com and Wesfarmers. The Motley Fool Australia has recommended Kogan.com and Wesfarmers. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Commonwealth Bank of Australia (ASX: CBA) shares have softened 0.1% at the time of writing on Tuesday afternoon, to $164.43 a piece. 

For context, the S&P/ASX 200 Index (ASX: XJO) is down 0.52% at the time of writing.

Despite today’s slightly lower price, CBA shares have now rebounded 7% from a 14% crash earlier this month. 

The drop came after the banking giant posted a disappointing third-quarter capital market update on the 13th of May, reporting flat operating income and a 1% decline in its unaudited cash NPAT. 

Investors were spooked by the results and rushed to sell up their shares, sending the share price tumbling in what was its biggest one-day fall on record.

But as quickly as the stock crashed, it started to rebound.

Why are CBA shares climbing higher again?

CBA shares have climbed steadily higher following the announcement, now recouping around 7% of losses that were shed.

There hasn’t been any price-sensitive news out of the banking giant since the update, so the rebound is likely sentiment-driven.

It looks like investors considered the sharp sell-off to be excessive. It’s also likely that after the panic selling eased, bargain-hunting investors started snapping up the shares for cheap.

Cooling concerns around mortgage, credit growth, and negative gearing changes also helped the bank’s share price rebound. 

The night before CBA released its trading update, Treasurer Jim Chalmers delivered the latest federal budget, where he outlined a structural change to negative gearing. He said that under the new rules, negative gearing would only apply to newly built homes, ending tax deductions for losses on existing residential investment properties. Investors initially reacted negatively.

CBA is a classic blue-chip stock

The banking giant is also supported by a flight to quality. In unstable markets, investors often rotate into large companies with stable dividends and dominant market positions to mitigate volatility. 

As a bank, CBA is mostly considered a cyclical stock, but it also has defensive assets. Australians will always need banking. From home loans to credit cards and even bank accounts. Banking is an essential service, rather than a discretionary spend.

It looks like CBA is the safe-haven stock of choice for investors right now.

Is CBA a buy, sell, or hold?

Analysts are mostly bearish on the outlook for CBA shares, with consensus of a downturn ahead. TradingView data shows that 14 out of 16 analysts have a sell or strong sell rating on the stock. 

The average target price is $127.57, which implies a 22% downside at the time of writing. But some think the share price could crash 45% to $90 in the next 12 months.

The post CBA shares rebound 7%: Is the banking giant a buy, sell or hold? appeared first on The Motley Fool Australia.

More reading

• Morgan Stanley tips 5% earnings downgrades for ASX 200 bank shares. Here’s why
• 4 reasons to buy CBA shares today
• Buy, hold, sell: Wesfarmers, Telstra, CBA shares
• Experts recommend CBA and these ASX shares as buys
• Why I think CBA shares are a blue-chip buy in June

Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The S&P/ASX 200 Index (ASX: XJO) is having a subdued session on Tuesday. In afternoon trade, the benchmark index is down 0.4% to 8,659.6 points.

Four ASX shares that are falling more than most today are listed below. Here’s why they are dropping:

ASX Ltd (ASX: ASX)

The ASX share price is down 12% to $51.72. This follows the release of guidance for FY 2027 from the stock exchange operator this morning. ASX revealed that FY 2027 total expense growth is expected to be between 18% and 21%. It advised: “This is primarily driven by technology modernisation, the expanded Accelerate Program as part of our response to the ASIC Inquiry and investments to support customer-driven growth.” The company has also increased its capex guidance for FY 2027. It now expects capex of $180 million to $200 million (from $160 million to $180 million). It then expects capex of $170 million to $190 million in FY 2028.

Challenger Ltd (ASX: CGF)

The Challenger share price is down 5% to $8.88. This is despite the annuities company releasing its investor day update and speaking positively about its outlook. Challenger’s CEO, Nick Hamilton, said: “Our transformation of recent years has brought us to this moment as a simpler, more focused business. We’re building the bridge between the accumulation system and the retirement system through distribution partnerships, advice and product innovation, and customer education. We’re making guaranteed income accessible in ways it simply wasn’t before. I have never been more confident in our strategic position, or more excited for the opportunity that’s here.”

Flight Centre Travel Group Ltd (ASX: FLT)

The Flight Centre share price is down over 3% to $9.95. The catalyst for this has been the release of a trading update from the travel agent this morning. Flight Centre advised that for the nine months to 31 March, it achieved a 7.6% year-on-year increase in total transaction value (TTV) to $19.5 billion. While this was solid, investors appear concerned with its performance since the end of March. Management advised that it has been “heavily impacted by Middle East tensions.” It estimates that it lost $10 million in profits in April because of the tensions due to increased refunds. Looking ahead, it warned: “May and June are typically stronger leisure trading months and ongoing volatility leading to cancellations, refunds and reduced forward bookings could be expected to have greater impact in those months.”

Goodman Group (ASX: GMG)

The Goodman share price is down 2% to $29.41. This morning, this industrial property company released its third-quarter update and revealed strong numbers. And while it is now expecting to at least achieve its operating earnings per share growth guidance in FY 2026, it seems that some investors were betting on a firmer guidance upgrade.

The post Why ASX, Challenger, Flight Centre, and Goodman shares are falling today appeared first on The Motley Fool Australia.

More reading

• Why Flight Centre, Goodman and Mineral Resources shares are creating a buzz on Tuesday
• ASX shares sink 8% as investors baulk at spending surge
• Down 32% this year, why are Flight Centre shares sinking again today?
• Why are Goodman shares tumbling 5% today?
• Why these ASX real estate stocks could be sleeping giants

Motley Fool contributor James Mickleboro has positions in Goodman Group. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Goodman Group. The Motley Fool Australia has recommended Challenger, Flight Centre Travel Group, and Goodman Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The S&P/ASX 200 Index (ASX: XJO) is losing ground on Tuesday, with broad selling across the market and oil prices back in focus.

At the time of writing, the ASX 200 is down 0.48% to 8,650 points.

The benchmark index has fallen below its previous close of 8,692 points after touching an intraday low of 8,628.9 points. That marks its weakest level over the last 3 sessions.

The selling is fairly broad, with 9 of the 11 sectors in the red and 126 of the 200 stocks trading lower.

Property and financial stocks are doing much of the damage, while oil prices are adding another layer of uncertainty after a volatile few sessions.

Oil swings keep investors nervous

Oil prices are still doing a lot of the work in setting the tone for markets of late.

Earlier in the session, investors had been weighing the prospect of a possible US-Iran deal. Brent crude had dropped below US$95 a barrel as traders considered whether pressure around the Strait of Hormuz could ease.

But the relief didn’t last long.

Brent crude futures have bounced as much as 2.2% after recent US attacks on Iranian targets. US futures also trimmed part of their earlier gains, which added to the more cautious tone across the ASX.

The quick change in direction shows how sensitive markets remain to headlines out of the Middle East.

That has left investors dealing with another quick reversal in sentiment.

Property and financials drag on the index

Property stocks are doing some of the heavier work on the downside today, with Goodman Group Ltd (ASX: GMG) shares down around 2.46% to $29.31, despite the company reaffirming its earnings guidance.

The financial sector is also weighing on the ASX 200. Commonwealth Bank of Australia (ASX: CBA) shares are down 0.44% to $163.87, while Macquarie Group Ltd (ASX: MQG) is roughly flat at $240.20.

ASX Ltd (ASX: ASX) is one of the biggest drags, falling about 11.2% to $52.21 after its latest guidance pointed to another year of rapid expense growth.

Pexa Group Ltd (ASX: PXA) is also weaker, down around 6.3% to $10.76 after UBS cut its target price.

Some stocks are still finding buyers

Not every part of the market is being sold off today.

Fisher & Paykel Healthcare Corp Ltd (ASX: FPH) is one of the stronger performers, with its shares up around 7.4% to $35.62 after a solid earnings update.

Kogan.com Ltd (ASX: KGN) is also jumping outside the ASX 200, with its shares up around 15% to $3.96 after reporting stronger earnings growth.

Those moves show investors are still willing to reward companies that give them a clearer reason to buy.

But they aren’t doing enough to change the direction of the wider market.

The ASX 200 is now down around 0.7% in 2026 and about 1.5% over the past month. It remains up around 3.5% over the past year, but today’s trading shows how uneven the recent momentum has become.

The post ASX 200 sinks as oil shock puts investors back on edge appeared first on The Motley Fool Australia.

More reading

• $10,000 invested in Fortescue shares 12 months ago is now worth…
• Goodman Group reports $87.1 billion portfolio value as data centre demand grows
• Greatland Resources secures Havieron approvals, eyes next steps
• 5 things to watch on the ASX 200 on Tuesday
• Here are the top 10 ASX 200 shares today

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Goodman Group, Kogan.com, Macquarie Group, and PEXA Group. The Motley Fool Australia has positions in and has recommended Macquarie Group and PEXA Group. The Motley Fool Australia has recommended Goodman Group and Kogan.com. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Investors are still finding reasons to buy NRW Holdings Ltd (ASX: NWH) after a huge 12-month run.

The contractor’s shares are up 2.08% to $7.35 on Tuesday after the company announced a fresh batch of project wins.

It has already been a massive period for shareholders.

NRW shares have gained around 42% in 2026 and about 164% over the past year, putting the stock among the stronger performers on the ASX.

Here’s what was in the update.

Fredon locks in new work

According to the release, NRW’s wholly owned subsidiary Fredon has secured a suite of contracts across Victoria and Western Australia.

The contracts have a combined value of about $120 million.

Fredon provides electrical, communications, technology, and maintenance services across infrastructure, resources, commercial, and industrial markets.

The work is spread across several projects, rather than being tied to just one large contract.

It also spreads the risk and gives Fredon exposure to a mix of data centres, hospitals, student accommodation, and commercial infrastructure.

What the contracts cover

The biggest part of the update is tied to an existing data centre project in Leederville.

Fredon has secured an additional $9 million electrical package on the project, lifting its total contract value there to about $55 million. Completion is expected in August 2027.

The company has also won a $26 million electrical and communications package for the Bunbury Hospital redevelopment in Western Australia. NRW said the project will deliver one of the most modern hospital facilities in regional Australia, with work due to begin in April 2026.

Fredon has picked up a $16 million electrical, communications, ICT, and security package for a University of Western Australia project in Nedlands. Construction on the 14-storey development started in October 2025 and is scheduled to finish in June 2027.

It has also secured a $10 million electrical and security package at the 609 Wellington Street student accommodation project in Perth. The development will provide 835 student beds and is due to be completed in June 2027.

Why the work is getting noticed

NRW has long been known for its mining and civil infrastructure work, but Fredon adds another source of contract revenue.

Today’s update shows the group is also picking up work across areas outside traditional mining activity.

Hospitals, data centres, student accommodation, and commercial buildings all require large, complex electrical and technology packages.

Fredon CEO Scott Olsen said the awards reflect the business’ ability to deliver critical infrastructure projects in live operating environments across Australia.

NRW chief executive Jules Pemberton said the contracts highlight Fredon’s diversity and strength in regional communities.

After such a strong share price run, investors will still be watching whether NRW can keep adding work at attractive margins.

The stock now has a market cap of about $3.4 billion and trades on a high price-to-earnings ratio (P/E) of 70.

The post This ASX 200 stock is up 164% in a year and still winning work appeared first on The Motley Fool Australia.

More reading

• Here are the top 10 ASX 200 shares today
• Here are the top 10 ASX 200 shares today
• Here are the top 10 ASX 200 shares today

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.